LifeStance Health Group (LFST) Has Rallied Sharply, Is The Stock Still Undervalued?

September 6, 2026 - 02:57

LifeStance Health Group is turning heads on Wall Street again. The mental health services provider has seen its shares surge sharply in recent weeks, continuing a longer run that has caught the attention of both momentum traders and value investors. With the stock trading near $12.73, the company has delivered a 22.76% gain over the past month and a striking 71.79% jump over the last three months.

That kind of move naturally raises a question: after such a strong rally, is there still room to run, or has the easy money been made? The longer-term numbers are even more dramatic. LifeStance shares have delivered a total shareholder return of 137.06% over the past year, a figure that reflects a steady recovery from the depressed levels seen in prior years.

The company operates a large network of outpatient mental health clinics across the United States, a business that has benefited from growing demand for behavioral health services. Investors have been encouraged by signs of improving operational efficiency and a clearer path toward profitability. The recent price action suggests the market is beginning to price in a more optimistic outlook for the company's growth trajectory.

Still, some analysts caution that the rapid appreciation may have stretched the valuation. While the stock is no longer the deep value play it was a year ago, supporters argue that the underlying fundamentals, including revenue growth and clinic expansion, justify a higher multiple than the market previously assigned. For now, the debate centers on whether the current price already reflects the good news or if LifeStance still has meaningful upside left as it continues to scale its platform.